Metabolites
Displaying compounds 1651 - 1675 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB13287 | LPA(25:1(11Z)/0:0) | {2-hydroxy-3-[(11Z)-pentacos-11-enoyloxy]propoxy}phosphonic acid | C28H55O7P 534.715 | |
| YMDB13306 | LPA(0:0/25:1(9Z)) | {3-hydroxy-2-[(9Z)-pentacos-9-enoyloxy]propoxy}phosphonic acid | C28H55O7P 534.715 | |
| YMDB13307 | LPA(0:0/25:1(11Z)) | {3-hydroxy-2-[(11Z)-pentacos-11-enoyloxy]propoxy}phosphonic acid | C28H55O7P 534.715 | |
| YMDB16272 | 4-Amino-4-deoxy-L-arabinose | [({[(2R,3R,4S,5S)-5-amino-3,4-dihydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | C14H23N3O15P2 535.291 | |
| YMDB01735 | Malvidin 3-O-(acetylglucoside) | 3-{[(2S,3R,4S,5S,6R)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1λ⁴-chromen-1-ylium | C25H27O13 535.4741 | |
| YMDB00239 | lipoyl-AMP | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[5-(1,2-dithiolan-3-yl)pentanoyl]oxy})phosphinic acid | C18H26N5O8PS2 535.532 | |
| YMDB13414 | PA(10:0/14:0) | [(2R)-3-(decanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphonic acid | C27H53O8P 536.687 | |
| YMDB13417 | PA(12:0/12:0) | [(2R)-2,3-bis(dodecanoyloxy)propoxy]phosphonic acid | C27H53O8P 536.687 | |
| YMDB01126 | DG(14:1(9Z)/16:1(9Z)/0:0) 3738-74-7 | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (9Z)-hexadec-9-enoate | C33H60O5 536.838 | |
| YMDB12769 | DG(14:1(11Z)/16:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl (11Z)-hexadec-11-enoate | C33H60O5 536.838 | |
| YMDB12770 | DG(14:1(11Z)/16:1(9Z)/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl (9Z)-hexadec-9-enoate | C33H60O5 536.838 | |
| YMDB12796 | DG(14:1(9Z)/16:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (11Z)-hexadec-11-enoate | C33H60O5 536.838 | |
| YMDB12850 | DG(15:1(11Z)/15:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(11Z)-pentadec-11-enoyloxy]propan-2-yl (11Z)-pentadec-11-enoate | C33H60O5 536.838 | |
| YMDB12851 | DG(15:1(11Z)/15:1(9Z)/0:0) | (2R)-3-hydroxy-2-[(9Z)-pentadec-9-enoyloxy]propyl (11Z)-pentadec-11-enoate | C33H60O5 536.838 | |
| YMDB12883 | DG(15:1(9Z)/15:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(9Z)-pentadec-9-enoyloxy]propan-2-yl (11Z)-pentadec-11-enoate | C33H60O5 536.838 | |
| YMDB12884 | DG(15:1(9Z)/15:1(9Z)/0:0) | (2R)-1-hydroxy-3-[(9Z)-pentadec-9-enoyloxy]propan-2-yl (9Z)-pentadec-9-enoate | C33H60O5 536.838 | |
| YMDB01515 | beta-Carotene 7235-40-7 | 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9Z,11Z,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-1-ene | C40H56 536.8726 | |
| YMDB00867 | CDP-ribitol 3506-17-0 | {[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4S)-2,3,4,5-tetrahydroxypentyl]oxy})phosphoryl]oxy})phosphinic acid | C14H25N3O15P2 537.3069 | |
| YMDB13852 | PE-NMe(10:0/10:0) | [2,3-bis(decanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C26H52NO8P 537.675 | |
| YMDB01125 | DG(14:0/16:1(9Z)/0:0) 3738-74-7 | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (9Z)-hexadec-9-enoate | C33H62O5 538.854 | |
| YMDB12690 | DG(10:0/20:1(11Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (11Z)-icos-11-enoate | C33H62O5 538.854 | |
| YMDB12691 | DG(10:0/20:1(13Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (13Z)-icos-13-enoate | C33H62O5 538.854 | |
| YMDB12717 | DG(12:0/18:1(11Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (11Z)-octadec-11-enoate | C33H62O5 538.854 | |
| YMDB12718 | DG(12:0/18:1(9Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate | C33H62O5 538.854 | |
| YMDB12743 | DG(14:0/16:1(11Z)/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (11Z)-hexadec-11-enoate | C33H62O5 538.854 |